BRINGING SURGICAL TECHNOLOGIES TO MARKET

End-to-end expertise for surgical innovation

From robotic surgical platforms and enabling technologies to oncology, breast reconstruction, and advanced surgical devices, bringing innovation into the operating room requires more than product development. Success depends on generating clinical evidence, optimizing usability, demonstrating economic value, and driving adoption within complex healthcare systems. IQVIA MedTech helps surgical innovators navigate these challenges with integrated support from development through commercialization. 

Integrated expertise for complex surgical technologies

General surgery remains one of the most dynamic and rapidly evolving sectors in medtech. Innovations in robotics, digital health, oncology, reconstructive surgery, and software-enabled devices continue to transform patient care while introducing new levels of development and regulatory complexity.

IQVIA MedTech serves as a strategic partner throughout the product lifecycle, helping emerging, mid-sized, and established medtech companies navigate development challenges through integrated clinical, regulatory, reimbursement, quality, and commercialization services.

MedTech Medical team performing surgery

Comprehensive general surgery & robotic device regulatory consulting

Navigate global requirements with targeted general surgery device regulatory consulting. Our team — including former FDA reviewers and notified body experts — drafts, compiles, and defends high-stakes submissions, including 510(k)s, De Novos, PMAs, and EU MDR technical documentation.

Robotic assisted surgery machine with surgery lights

Dedicated general surgery & robotic device clinical research

Maximize clinical trial efficiency and accuracy. We offer specialized general surgery and robotic device clinical research services, covering protocol architecture, site selection, trial execution, biostatistical analysis, complex registries, and pivotal IDE studies.

MedTechClose up heart surgery in hospital horizontal composition

Commercialization, health economics & reimbursement

Design a clear pathway for robotic device commercialization. We integrate health economics and outcomes research (HEOR) with coverage, coding, and payment strategies to help ensure your technology is successfully adopted and reimbursed by global payers.

End-to-end quality assurance & compliance systems

Establish and maintain audit-ready quality management system regulation (QMSR). We deliver specialized quality remediation, ISO 14971 risk management architecture, and post-market surveillance (PMS) support tailored to the complex design and manufacturing demands of advanced surgical technologies.

Targeted expertise across general surgery device sectors

Our consultants actively support a wide array of specialized hardware and sensing technologies, ensuring that your unique engineering architecture meets stringent clinical standards. They include, but are not limited to:

  • Surgical Robotics
  • Oncology Devices
  • Breast Reconstruction
  • Urology Technologies
  • Reproductive Health
  • General Surgery & Hospital Device

Navigating the future of advanced general surgery therapies

As therapy areas converge, our multidisciplinary team excels at managing complex, next-generation solutions. Our teams integrate expertise across:

  • Cybersecurity
  • Digital health software
  • Human factors engineering
  • Biocompatibility
  • EMC testing
MCRA IS NOW PART OF IQVIA MEDTECH
Advancing Precision, Healing, and Aesthetic Innovation in Surgical Care
From advanced biomaterials and surgical mesh to light therapy devices, dermal fillers, and first-in-class surgical tools, IQVIA MedTech and MCRA guide medical device innovators through every step of the development cycle.

Frequently asked questions about general surgery device consulting

As our Director of Regulatory Affairs, Robotics & EMC Somi Ekwealor notes, “The most successful medical device companies engage regulatory early and often, using it as a strategic enabler rather than a hurdle.” Our integrated methodology ensures your clinical trial design explicitly captures the safety, efficacy, and HEOR data needed for regulatory approvals and payer coverage.
We have a dedicated digital health team that specializes in AI, machine learning algorithms, and remote monitoring tools. We help developers classify their software, navigate FDA pre-submissions, manage cybersecurity expectations, and prove clinical validity.
Yes. Our global regulatory consulting network routinely conducts gap analyses, updates clinical evaluation reports (CERs), and restructures technical documentation to maintain compliance and avoid market disruption under EU MDR rules.
Ready to advance your next general surgery breakthrough?

Partner with experts across clinical development, regulatory strategy, and commercialization to accelerate your path to market.